The use of Tablo continuous veno-venous haemodialysis to rapidly remove lithium in a patient with severe lithium toxicity.

Brian Nohomovich, Emmanuel Tito, Michael Terrio, Matthew Belardo
Author Information
  1. Brian Nohomovich: Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA bnohomovich@gmail.com. ORCID
  2. Emmanuel Tito: Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA. ORCID
  3. Michael Terrio: Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA.
  4. Matthew Belardo: Internal Medicine, Western Michigan University Homer Stryker MD School of Medicine, Kalamazoo, Michigan, USA.

Abstract

We report a case of severe, life-threatening lithium toxicity in a patient with bipolar I disorder who presented with altered mental status and acute renal failure. At admission, serum lithium level was well above toxic levels (>2 mEq/L). The signs and symptoms of lithium toxicity significantly improved after treatment with continuous veno-venous haemodialysis (CVVHD). The patient was discharged with no neurological or renal sequelae. Herein is the first case report using the Tablo CVVHD system to treat severe lithium toxicity.

Keywords

References

  1. Kidney Int. 1997 Jun;51(6):2013-7 [PMID: 9186896]
  2. Pharmacol Biochem Behav. 1984;21 Suppl 1:57-64 [PMID: 6240662]
  3. Proc Natl Acad Sci U S A. 1995 Feb 14;92(4):1013-7 [PMID: 7532304]
  4. Am J Nephrol. 2000 Sep-Oct;20(5):408-11 [PMID: 11093000]
  5. Am J Physiol Renal Physiol. 2016 Dec 1;311(6):F1168-F1171 [PMID: 27122541]
  6. BMC Nephrol. 2015 Feb 14;16:20 [PMID: 25884763]
  7. World J Surg. 2008 Oct;32(10):2195-9 [PMID: 18463919]
  8. Am J Physiol Renal Physiol. 2000 Sep;279(3):F552-64 [PMID: 10966935]
  9. J Intensive Care Med. 2017 May;32(4):249-263 [PMID: 27516079]
  10. J Clin Endocrinol Metab. 1997 Sep;82(9):2844-8 [PMID: 9284708]
  11. Chest. 2019 Mar;155(3):626-638 [PMID: 30266628]
  12. J Am Soc Nephrol. 1999 Mar;10(3):647-63 [PMID: 10073616]
  13. J Am Soc Nephrol. 2011 Feb;22(2):253-61 [PMID: 21051735]
  14. Am J Kidney Dis. 2000 Jan;35(1):105-11 [PMID: 10620551]
  15. Hemodial Int. 2020 Jan;24(1):22-28 [PMID: 31697042]
  16. BMC Nephrol. 2022 Oct 21;23(1):338 [PMID: 36271326]
  17. Kidney Res Clin Pract. 2013 Sep;32(3):96-102 [PMID: 26877923]
  18. World J Surg. 2018 Feb;42(2):415-424 [PMID: 29260296]
  19. Eur J Endocrinol. 2009 Feb;160(2):317-23 [PMID: 19001061]
  20. Thyroid. 1998 Oct;8(10):909-13 [PMID: 9827658]
  21. Ren Replace Ther. 2021;7(1):43 [PMID: 34367669]

MeSH Term

Humans
Lithium
Continuous Renal Replacement Therapy
Renal Dialysis
Antidepressive Agents
Bipolar Disorder

Chemicals

Lithium
Antidepressive Agents

Word Cloud

Created with Highcharts 10.0.0lithiumtoxicityseverepatientreportcaserenalcontinuousveno-venoushaemodialysisCVVHDTablolife-threateningbipolardisorderpresentedalteredmentalstatusacutefailureadmissionserumlevelwelltoxiclevels>2mEq/LsignssymptomssignificantlyimprovedtreatmentdischargedneurologicalsequelaeHereinfirstusingsystemtreatuserapidlyremoveDialysisMooddisordersincludingdepressionToxicology

Similar Articles

Cited By